Surf AccountsProduction v1.0.0 v1.0.0 2022-02-04 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is the provision of cosmetic medical treatments. 1 November 2023 0 NI685533 2023-02-28 NI685533 2022-02-03 NI685533 2022-02-04 2023-02-28 NI685533 uk-bus:PrivateLimitedCompanyLtd 2022-02-04 2023-02-28 NI685533 uk-curr:PoundSterling 2022-02-04 2023-02-28 NI685533 uk-bus:SmallCompaniesRegimeForAccounts 2022-02-04 2023-02-28 NI685533 uk-bus:FullAccounts 2022-02-04 2023-02-28 NI685533 uk-core:ShareCapital 2023-02-28 NI685533 uk-core:RetainedEarningsAccumulatedLosses 2023-02-28 NI685533 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2023-02-28 NI685533 uk-bus:FRS102 2022-02-04 2023-02-28 NI685533 uk-core:WithinOneYear 2023-02-28 NI685533 uk-core:AfterOneYear 2023-02-28 NI685533 uk-core:EmployeeBenefits 2022-02-03 NI685533 uk-core:EmployeeBenefits 2022-02-04 2023-02-28 NI685533 uk-core:AcceleratedTaxDepreciationDeferredTax 2023-02-28 NI685533 uk-core:TaxLossesCarry-forwardsDeferredTax 2023-02-28 NI685533 uk-core:OtherDeferredTax 2023-02-28 NI685533 uk-core:RevaluationPropertyPlantEquipmentDeferredTax 2023-02-28 NI685533 uk-core:EmployeeBenefits 2023-02-28 NI685533 2022-02-04 2023-02-28 NI685533 uk-bus:Director1 2022-02-04 2023-02-28 NI685533 uk-bus:AuditExempt-NoAccountantsReport 2022-02-04 2023-02-28 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
Company Registration Number: NI685533
 
 
Skinpharm Aesthetic Solutions Ltd
 
Unaudited Financial Statements
 
for the financial period from 4 February 2022 (date of incorporation) to 28 February 2023
Skinpharm Aesthetic Solutions Ltd
Company Registration Number: NI685533
BALANCE SHEET
as at 28 February 2023

Feb 23
Notes £
 
Current Assets
Stocks 6 505
Cash and cash equivalents 571
─────────
1,076
─────────
Creditors: amounts falling due within one year 7 (850)
─────────
Net Current Assets 226
─────────
Total Assets less Current Liabilities 226
 
Creditors:
amounts falling due after more than one year 8 (3,828)
 
Provisions for liabilities 9 686
─────────
Net Liabilities (2,916)
═════════
 
Capital and Reserves
Called up share capital 10
Income and expenditure account (2,926)
─────────
Equity attributable to owners of the company (2,916)
═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
       
The company has taken advantage of the exemption under section 444 not to file the Income and Expenditure Account and Director's Report.
       
For the financial period from 4 February 2022 (date of incorporation) to 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
       
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial period in question in accordance with section 476 of the Companies Act 2006.
       
The director acknowledges her responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial period and of its profit and loss for the financial period in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
       
Approved by the Director and authorised for issue on 1 November 2023
       
       
________________________________      
Carmel Burns      
Director      
       



Skinpharm Aesthetic Solutions Ltd
NOTES TO THE FINANCIAL STATEMENTS
for the financial period from 4 February 2022 (date of incorporation) to 28 February 2023

   
1. General Information
 
Skinpharm Aesthetic Solutions Ltd is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI685533. The registered office of the company is 1c Aghee Road, Omagh, Co Tyrone, BT78 5LF, Northern Ireland which is also the principal place of business of the company. The principal activity of the company is the provision of cosmetic medical treatments. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial period ended 28 February 2023 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Income
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Stocks
Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Borrowing costs
Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
 
Provisions
Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable income for the financial period and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable income and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Income and Expenditure Account.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
   
3. Period of financial statements
 
The financial statements are for the 12 month 25 days period from 4 February 2022 (date of incorporation) to 28 February 2023.
   
4. Going concern
 
The balance sheet shows a deficiency of assets on a historical cost basis of £2,916. As the deficiency has been created by the existence of loans from the director which are not payable in the foreseeable future, it is considered that the preparation of the accounts on the going concern basis is appropriate.
     
5. Employees
 
The average monthly number of employees, including director, during the financial period was 0, (Feb 22 - 0).
     
6. Stocks Feb 23
  £
 
Finished goods and goods for resale 505
  ═════════
 
The replacement cost of stock did not differ significantly from the figures shown.
     
7. Creditors Feb 23
Amounts falling due within one year £
 
Accruals 850
  ═════════
     
8. Creditors Feb 23
Amounts falling due after more than one year £
 
Director's loan accounts 3,828
  ═════════
 
       
9. Provisions for liabilities
 
The amounts provided for deferred taxation are analysed below:
 
    Total
     
     
    Feb 23
  £ £
 
At financial period start - -
Charged to income and expenditure (686) (686)
  ───────── ─────────
At financial period end (686) (686)
  ═════════ ═════════
     
10. Capital commitments
 
The company had no material capital commitments at the financial period-ended 28 February 2023.
         
11. Related party transactions
 
During the year the company borrowed £5,922 and repaid £2,094 to the director. At the year end, the amount owed to the directors was £3,828 and this is included in the creditors section of the balance sheet.

There were no other related party transactions during the year.
   
12. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial period-end.